HCA
BIO icon

Harbor Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Harbor Capital Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,768
Closed -$839K – 1255
2025
Q4 		$839K Buy
2,768
+165
+6% +$51.5K 0.07% 365
2025
Q3 		$730K Sell
2,603
-6,651
-72% -$1.81M 0.06% 383
2025
Q2 		$2.23M Buy
9,254
+183
+2% +$43.3K 0.09% 272
2025
Q1 		$2.21M Buy
9,071
+1,247
+16% +$375K 0.1% 268
2024
Q4 		$2.57M Buy
7,824
+321
+4% +$109K 0.11% 237
2024
Q3 		$2.51M Buy
7,503
+3,840
+105% +$1.22M 0.11% 255
2024
Q2 		$1M Buy
3,663
+2,792
+321% +$812K 0.08% 356
2024
Q1 		$301K Buy
+871
New +$286K 0.04% 521
2023
Q4 		– Sell
-1,110
Closed -$398K – 439
2023
Q3 		$398K Sell
1,110
-116
-9% -$44.8K 0.09% 258
2023
Q2 		$465K Buy
1,226
+3
+0.2% +$1.22K 0.09% 257
2023
Q1 		$586K Sell
1,223
-120
-9% -$56.2K 0.17% 123
2022
Q4 		$565K Sell
1,343
-29
-2% -$11.7K 0.55% 60
2022
Q3 		$572K Sell
1,372
-153
-10% -$76.3K 0.53% 60
2022
Q2 		$755K Sell
1,525
-34
-2% -$17.7K 0.57% 56
2022
Q1 		$878K Buy
1,559
+49
+3% +$29.5K 0.41% 66
2021
Q4 		$1.14M Buy
+1,510
New +$1.13M 0.42% 67

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harbor Capital Advisors's BIO Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 2,768 shares — an estimated $839K sold.

Harbor Capital Advisors first reported a position in BIO in Q4 2021 and held it in 16 quarters. The position peaked at $2.57M in Q4 2024. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 2,768 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $839K.
  • Harbor Capital Advisors first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 16 quarters.
  • Harbor Capital Advisors's Bio-Rad Laboratories Class A position peaked at $2.57M in Q4 2024.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.